Related Experiment Video
Updated: Aug 9, 2025

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain
Lili Sun1, Jie Zhang2, Changshan Niu3
1Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
Abstract:
Pain is often debilitating, and current treatments are neither universally efficacious nor without risks. Transient receptor potential (TRP) ion channels offer alternative targets for pain relief, but little is known about the regulation or identities of endogenous TRP ligands that affect inflammation and pain. Here, transcriptomic and targeted lipidomic analysis of damaged tissue from the mouse spinal nerve ligation (SNL)-induced chronic pain model revealed a time-dependent increase in Cyp1b1 mRNA and a concurrent accumulation of 8,9-epoxyeicosatrienoic acid (EET) and 19,20-EpDPA post injury. Production of 8,9-EET and 19,20-EpDPA by human/mouse CYP1B1 was confirmed in vitro, and 8,9-EET and 19,20-EpDPA selectively and dose-dependently sensitized and activated TRPA1 in overexpressing HEK-293 cells and Trpa1-expressing/AITC-responsive cultured mouse peptidergic dorsal root ganglia (DRG) neurons. TRPA1 activation by 8,9-EET and 19,20-EpDPA was attenuated by the antagonist A967079, and mouse TRPA1 was more responsive to 8,9-EET and 19,20-EpDPA than human TRPA1. This latter effect mapped to residues Y933, G939, and S921 of TRPA1. Intra-plantar injection of 19,20-EpDPA induced acute mechanical, but not thermal hypersensitivity in mice, which was also blocked by A967079. Similarly, Cyp1b1-knockout mice displayed a reduced chronic pain phenotype following SNL injury. These data suggest that manipulation of the CYP1B1-oxylipin-TRPA1 axis might have therapeutic benefit.
Insights
Researchers identified a new pathway involving CYP1B1, oxylipins like 8,9-EET, and TRPA1 channels that contributes to chronic pain. Targeting this axis may offer novel pain relief strategies.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Chronic pain is a significant health issue with limited effective treatments.
- Transient receptor potential (TRP) ion channels are potential targets for pain management.
- Endogenous ligands regulating TRP channels in pain and inflammation are not well understood.
Purpose of the Study:
- To investigate the role of CYP1B1 and its lipid products in chronic pain.
- To identify endogenous ligands that activate TRP channels involved in pain signaling.
- To explore the therapeutic potential of targeting the CYP1B1-oxylipin-TRPA1 axis.
Main Methods:
- Transcriptomic and lipidomic analysis of a mouse spinal nerve ligation (SNL) pain model.
- In vitro confirmation of 8,9-epoxyeicosatrienoic acid (EET) and 19,20-EpDPA production by CYP1B1.
- Functional assays using HEK-293 cells and cultured mouse neurons to assess TRPA1 channel activity.
- Pharmacological inhibition of TRPA1 and genetic knockout of Cyp1b1 in mice.
Main Results:
- SNL injury increased Cyp1b1 mRNA and led to accumulation of 8,9-EET and 19,20-EpDPA.
- These oxylipins activated and sensitized the TRPA1 channel in a dose-dependent manner.
- Cyp1b1-knockout mice showed reduced chronic pain, and 19,20-EpDPA induced mechanical hypersensitivity blocked by TRPA1 inhibition.
Conclusions:
- The CYP1B1-oxylipin-TRPA1 pathway is implicated in the development of chronic pain.
- 8,9-EET and 19,20-EpDPA are endogenous TRPA1 agonists relevant to pain.
- Targeting the CYP1B1-oxylipin-TRPA1 axis presents a promising therapeutic strategy for pain management.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Pain
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Nociception
Mechanically-gated Ion Channels

